High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis

被引:37
作者
Orell-Kotikangas, Helena [2 ,3 ]
Schwab, Ursula [4 ,5 ]
Osterlund, Piao [3 ]
Saarilahti, Kauko [3 ]
Makitie, Outi [6 ]
Makitie, Antti A. [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Otolaryngol Head & Neck Surg, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Clin Nutr Therapy, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
[4] Univ Eastern Finland, Dept Clin Nutr, Kuopio, Finland
[5] Kuopio Univ Hosp, Inst Internal Med, SF-70210 Kuopio, Finland
[6] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2012年 / 34卷 / 10期
关键词
oncology; survival; etiology; calcium; cholecalciferol; 25-HYDROXYVITAMIN D LEVELS; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; BREAST-CANCER; COLORECTAL-CANCER; COLON-CANCER; HYPOVITAMINOSIS-D; MORTALITY-RATES; SUBSEQUENT RISK; D DEFICIENCY;
D O I
10.1002/hed.21954
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Low serum levels of vitamin D, measured as serum 25-hydroxy-vitamin D (S-25-OHD), have been observed in several cancers. Methods Sixty-five adult patients with head and neck cancer, 50 men, median age 61 years (range, 3377 years), were enrolled in this prospective cohort study. Concentrations of S-25-OHD and plasma calcium (Ca) and phosphate (Pi) were measured before cancer treatment. Results The mean S-25-OHD was 42.0 (SD 22) nmol/L. Hypovitaminosis D (37.550 nmol/L) was found in 20% of the patients and vitamin D deficiency (<37.5 nmol/L) in 45% of the patients. No seasonal variation was seen. Subnormal plasma Ca and Pi levels were found in 11% and 9% of the patients, respectively. Conclusion Subnormal vitamin D levels were found in a significant proportion of the patients. Because vitamin D deficiency may pose these patients to increased risk of therapy-related morbidity, special attention should be paid to correction of this nutritional deficiency. (c) 2012 Wiley Periodicals, Inc. Head Neck, 2012
引用
收藏
页码:1450 / 1455
页数:6
相关论文
共 56 条
  • [1] ABEHASHIMOTO J, 1993, CANCER RES, V53, P2534
  • [2] Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
    Ahonen, MH
    Tenkanen, L
    Teppo, L
    Hakama, M
    Tuohimaa, P
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (09) : 847 - 852
  • [3] Vitamin D-3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model
    Akhter, J
    Chen, XH
    Bowrey, P
    Bolton, EJ
    Morris, DL
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (03) : 317 - 321
  • [4] Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators
    Beer, Tomasz M.
    Ryan, Christopher W.
    Venner, Peter M.
    Petrylak, Daniel P.
    Chatta, Gurkamal S.
    Ruether, J. Dean
    Redfern, Charles H.
    Fehrenbacher, Louis
    Saleh, Mansoor N.
    Waterhouse, David M.
    Carducci, Michael A.
    Vicario, Daniel
    Dreicer, Robert
    Higano, Celestia S.
    Ahmann, Frederick R.
    Chi, Kim N.
    Henner, W. David
    Arroyo, Alan
    Clow, Fong W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) : 669 - 674
  • [5] Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
    Bischoff-Ferrari, Heike A.
    Giovannucci, Edward
    Willett, Walter C.
    Dietrich, Thomas
    Dawson-Hughes, Bess
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (01) : 18 - 28
  • [6] Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland
    Brock, K. E.
    Graubard, B. I.
    Fraser, D. R.
    Weinstein, S. J.
    Stolzenberg-Solomon, R. Z.
    Lim, U.
    Tangrea, J. A.
    Virtamo, J.
    Ke, L.
    Snyder, K.
    Albanes, D.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2010, 64 (03) : 280 - 288
  • [7] Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database
    Carvalho, AL
    Nishimoto, IN
    Califano, JA
    Kowalski, LP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (05) : 806 - 816
  • [8] Vitamin D, calcium, and breast cancer risk: A review
    Cui, Yan
    Rohan, Thomas E.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (08) : 1427 - 1437
  • [9] A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
    Dalhoff, K
    Dancey, J
    Astrup, L
    Skovsgaard, T
    Hamberg, KJ
    Lofts, FJ
    Rosmorduc, O
    Erlinger, S
    Hansen, JB
    Steward, WP
    Skov, T
    Burcharth, F
    Evans, TRJ
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (02) : 252 - 257
  • [10] Estimates of optimal vitamin D status
    Dawson-Hughes, B
    Heaney, RP
    Holick, MF
    Lips, P
    Meunier, PJ
    Vieth, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (07) : 713 - 716